This phase III trial studies how well lenalidomide and dexamethasone works with or without daratumumab in treating patients with high-risk smoldering myeloma.
This trial is currently open and accepting patients.
The following criteria is a partial list of reasons why patients may be eligible to participate in this clinical trial. Further evaluation with a medical professional is required.
Inclusion Criteria:
Phase 3
Enrollment: 288 patients (estimated)
View MoreRead the latest news and updates on this trial.
February 05, 2019
In patients with newly diagnosed multiple myeloma who are not eligible for stem cell transplantation, the addition of daratumumab to lenalidomide and dexamethasone significantly reduced the risk of death or disease progression by 44%, according to a late-breaking abstract presentation by Thierry Facon, MD, of the Hospital Claude Huriez in Lille, France, at the 2018 American Society of Hematology (ASH) Annual Meeting & Exposition.
View all clinical trial locations sorted by state.
Birmingham, AL
Santa Maria, CA
Colorado Springs, CO
Denver, CO
Lone Tree, CO
Savannah, GA
Harvey, IL
Springfield, IL
Des Moines, IA
Louisville, KY
Ann Arbor, MI
Kalamazoo, MI
Marlette, MI
Southfield, MI
St. Louis, MO
Omaha, NE
Las Vegas, NV
Las Vegas, NV
Las Vegas, NV
Las Vegas, NV
Las Vegas, NV
Spring Valley, NV
New York, NY
Chapel Hill, NC
Greenville, NC
Cleveland, OH
Portland, OR
Dallas, TX
Fort Worth, TX
Seattle, WA
Madison, WI
We know how difficult and confusing this process can be. If you are interested in this clinical trial or have questions, you can call us at any time. You can also send us a direct message with questions.
(888) 828-2206If you are interested in keeping an eye on this trial, you can add it to your list of favorite trials. We'll send you alerts when this trial is updated.
You can explore trial locations from around the US and connect directly with a trial coordinator.
Find Nearby LocationsYou can print an overview of this trial to take in to your next appointment. Your doctor can help you understand if this trial may be right for you.
Still need help? Send us a message